Return to Emergent BioSolutions

    The Demand for Nanoparticles in Drug Formulation is Rising

    11.02.2022

    Demand for nanoparticles in the biopharmaceutical industry is on the rise. Production of these tiny particles, which can protect and deliver medicines and vaccines where they need to go in the body, has been increasing since 1989.

    Collaborating with an experienced partner, such as a CDMO, could prove to be invaluable in developing nano-based systems. 

    Read more about the benefits and challenges of nanoparticle production. 

    Download Article

     

    Emergent CDMO

    Thought Leadership Nanoparticles

    Related Stories

    03.22.2023

    How to Mitigate Risk for Biologics During Fill/Finish Manufacturing

    As more biologics move through research and development, the demand for specialized aseptic fill/finish services has steadily...

    READ MORE

    09.01.2020

    All Hands on Deck for Fill/Finish of Vaccines and Therapeutics

    “Emergent has a long, successful history of working with the US government to develop, manufacture, and deliver safe and...

    READ MORE

    06.24.2021

    Ondemand Webinar: MANUFACTURING NEXT-GEN THERAPIES  - THE VANRX SA25 ASEPTIC FILLING WORKCELL

    Our state-of-the-art Vanrx® SA25 Aseptic Filling Workcell can be deployed to support your clinical or commercial drug product...

    READ MORE